文献速递神经肿瘤

经鼻与经颅前颅底手术后生活质量与情绪负担

Quality of life and emotional burden after transnasal and transcranial anterior skull base surgery.
PubMed 文献 · Acta Neurochir (Wien) · 2019-10-10

该前瞻性研究纳入54例前颅底手术患者,40例完成3和12个月随访。术后病理性焦虑比例从75.0%降至45.0%(p=0.002),个体情绪负担从6.7降至4.0(p<0.001),经鼻与经颅两组无显著差异。两种入路均获得良好术后生活质量和精神病理学结局,术前心理困扰部分影响术后生活质量改善。

要点

  • 经鼻与经颅前颅底手术后生活质量和精神病理结局均良好
  • 术后病理性焦虑比例显著下降,两组无差异
  • 术前心理困扰影响术后生活质量改善,但术后趋于缓解

核心结论

  • 经鼻与经颅入路均获得良好的术后生活质量和精神病理学结局。
  • 术后生活质量的提高部分受术前心理困扰表达的影响,且术后趋于缓解。

研究设计与样本

  • 前瞻性研究,纳入2013年1月至2017年7月择期前颅底手术患者54例(垂体腺瘤或脑膜瘤)。
  • 40例(74.1%)完成术后3和12个月随访;女性60.0%,中位年龄57岁。
  • 57.5%为脑膜瘤经颅手术,42.5%为垂体腺瘤经鼻手术。
  • 术前、术后3和12个月评估抑郁(ADS-K)和焦虑(PTSS、STAI-S、STAI-T、ASI-3),并分析术前心理负担与术后SF-36和EuroQol生活质量的相关性。

主要发现

  • 病理性焦虑评分比例从75.0%显著降至45.0%(p=0.002),经鼻与经颅亚组间无差异。
  • 术后3个月全队列EuroQol VAS评分平均非显著增加0.07(p=0.236),经颅与经鼻亚组间无显著差异(p=0.478)。
  • 经鼻组焦虑评分倾向更高,经颅组抑郁评分更高,但均无显著差异。
  • 个体自述情绪负担在十点Likert量表上从6.7显著降至4.0(p<0.001),两亚组同等下降(经鼻-2.3,经颅-3.0;p=0.174)。
  • 末次检查时每亚组约半数患者(41.2% vs. 52.2%;p=0.491)报告术前躯体 complaints(头痛、头晕、不安)相当程度恢复(Likert量表评分至少8分)。

临床怎么用

  • 术前应评估患者的心理困扰(焦虑、抑郁),因其影响术后生活质量改善。
  • 经鼻与经颅入路术后精神病理结局相似,选择入路时可结合病变和手术需要,不必因心理结局差异而偏向某一入路。

局限性

  • 样本量较小(纳入54例,随访40例),可能影响统计效能和亚组比较。
  • 非随机设计,经鼻与经颅亚组对应不同疾病(垂体腺瘤 vs. 脑膜瘤),存在混杂。
  • 随访至术后12个月,但部分分析仅报告术后3个月数据,长期结局不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze psychopathological outcome and health-related quality of life (QOL) for cohorts of patients undergoing transcranial or transnasal anterior skull base surgery. METHODS: A prospective study of patients undergoing elective surgery for various entities of the anterior skull base was performed. Evaluation for depression (ADS-K score) and anxiety (PTSS, STAI-S, STAI-T, and ASI-3 scores) was done before surgery, at 3 and 12 months after surgery. The correlation between preoperative psychological burden and postoperative quality of life as measured by the SF-36 and EuroQol questionnaires was analyzed. Incidence and influence of these psychiatric comorbidities on clinical outcome were examined and compared between transnasal and transcranial subgroups. RESULTS: We included 54 patients scheduled for surgery of a pituitary adenoma or meningioma of the anterior skull base between January 2013 and July 2017. Of these, a cohort of 40 (74.1%) completed follow-up interviews after 3 and 12 months. There were 60.0% female patients, median age was 57 years. 57.5% of patients had a meningioma and were operated transcranially, while 42.5% of patients received transnasal surgery for pituitary adenoma. The proportion of pathological anxiety scores significantly decreased from 75.0 to 45.0% (p = 0.002), without difference between transnasal and transcranial subgroups. After 3 months, mean EuroQol VAS score non-significantly increased by 0.07 (p = 0.236) across the entire cohort without significant difference between transcranial and transnasal subgroups (p = 0.478). The transnasal cohort tended to score higher in anxiety scores, whereas the transcranial cohort demonstrated higher depression scores without significant difference, respectively. The individually declared emotional burden significantly decreased from 6.7 to 4.0 on the ten-point Likert scale (p < 0.001) equally for both subgroups (transnasal, - 2.3; transcranial, - 3.0; p = 0.174). On last examination, about half of the patients in each subgroup (41.2% vs. 52.2%; p = 0.491) expressed a considerable recovery of preoperative bodily complaints such as headaches, dizziness, and unrest defined as a score of at least 8 on the Likert scaled item. CONCLUSION: Both transnasal and transcranial approaches yield favorable postoperative QOL and psychopathological outcomes. The postoperative increase in QOL is partly influenced by preoperative expression of mental distress, which tends to resolve postoperatively.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Wagner A, Shiban Y, Kammermeier V, et al. Quality of life and emotional burden after transnasal and transcranial anterior skull base surgery. Acta Neurochir (Wien). 2019. PMID: 31602535. doi:10.1007/s00701-019-04062-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。